Ankit Ganeshpurkar

1.1k total citations
48 papers, 790 citations indexed

About

Ankit Ganeshpurkar is a scholar working on Pharmacology, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Ankit Ganeshpurkar has authored 48 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 23 papers in Computational Theory and Mathematics and 16 papers in Molecular Biology. Recurrent topics in Ankit Ganeshpurkar's work include Cholinesterase and Neurodegenerative Diseases (25 papers), Computational Drug Discovery Methods (23 papers) and Alzheimer's disease research and treatments (12 papers). Ankit Ganeshpurkar is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (25 papers), Computational Drug Discovery Methods (23 papers) and Alzheimer's disease research and treatments (12 papers). Ankit Ganeshpurkar collaborates with scholars based in India, United States and Germany. Ankit Ganeshpurkar's co-authors include Sushil Kumar Singh, Devendra Kumar, Ashok Kumar, Gopichand Gutti, Devendra Kumar, Gyan Modi, Dileep Kumar, Sanjeev Gupta, Sairam Krishnamurthy and Sukesh Kumar Gupta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Ethnopharmacology and RSC Advances.

In The Last Decade

Ankit Ganeshpurkar

44 papers receiving 775 citations

Peers

Ankit Ganeshpurkar
Ankit Ganeshpurkar
Citations per year, relative to Ankit Ganeshpurkar Ankit Ganeshpurkar (= 1×) peers Federica Prati

Countries citing papers authored by Ankit Ganeshpurkar

Since Specialization
Citations

This map shows the geographic impact of Ankit Ganeshpurkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankit Ganeshpurkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankit Ganeshpurkar more than expected).

Fields of papers citing papers by Ankit Ganeshpurkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankit Ganeshpurkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankit Ganeshpurkar. The network helps show where Ankit Ganeshpurkar may publish in the future.

Co-authorship network of co-authors of Ankit Ganeshpurkar

This figure shows the co-authorship network connecting the top 25 collaborators of Ankit Ganeshpurkar. A scholar is included among the top collaborators of Ankit Ganeshpurkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankit Ganeshpurkar. Ankit Ganeshpurkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganeshpurkar, Ankit, et al.. (2025). Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions. PubMed. 11(2). 162–184. 1 indexed citations
3.
Ganeshpurkar, Ankit, et al.. (2025). Mechanistic insights into angiotensin-converting enzyme inhibition by Apium graveolens through an integrative in silico–in vitro study. International Journal of Biological Macromolecules. 337(Pt 1). 149305–149305.
4.
Ganeshpurkar, Ankit, et al.. (2024). Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications. SHILAP Revista de lepidopterología. 3(1). 148–171. 38 indexed citations
5.
Gutti, Gopichand, Ankit Ganeshpurkar, Ashok Kumar, et al.. (2024). Centella asiatica improves memory and executive function in middle-aged rats by controlling oxidative stress and cholinergic transmission. Journal of Ethnopharmacology. 325. 117888–117888. 4 indexed citations
6.
Ganeshpurkar, Ankit, et al.. (2023). Small size silver nanoparticles loaded with glycoside rich portion of Boerhavia Diffusa Linn. promotes wound healing: in-silico and in-vivo studies. Colloids and Surfaces B Biointerfaces. 230. 113483–113483. 12 indexed citations
7.
Ganeshpurkar, Ankit, et al.. (2023). Effect of sulfonamide derivatives of phenylglycine on scopolamine‐induced amnesia in rats. SHILAP Revista de lepidopterología. 9(1). 13–31. 4 indexed citations
8.
Gutti, Gopichand, Kakarla Ramakrishna, Ankit Ganeshpurkar, et al.. (2023). Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 259. 115670–115670. 22 indexed citations
9.
Ganeshpurkar, Ankit, et al.. (2023). Preparation, Characterization, in-vitro and in-vivo Pharmacokinetic Evaluation of Thermostable Dimethyl Fumarate Cocrystals. Journal of Pharmaceutical Sciences. 113(3). 647–658. 2 indexed citations
10.
Anand, Asha, et al.. (2023). Machine learning-based screening of in-house database to identify BACE-1 inhibitors. Chemical Papers. 77(11). 6849–6858. 1 indexed citations
12.
Ganeshpurkar, Ankit, et al.. (2022). Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach. International Journal of Biological Macromolecules. 203. 195–211. 13 indexed citations
13.
Gutti, Gopichand, Kakarla Ramakrishna, Devendra Kumar, et al.. (2019). Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 182. 111613–111613. 34 indexed citations
14.
Gutti, Gopichand, Devendra Kumar, Ankit Ganeshpurkar, et al.. (2019). Development of pyrazole and spiropyrazoline analogs as multifunctional agents for treatment of Alzheimer’s disease. Bioorganic Chemistry. 90. 103080–103080. 46 indexed citations
15.
Kumar, Devendra, Ankit Ganeshpurkar, Dileep Kumar, et al.. (2018). Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead. European Journal of Medicinal Chemistry. 148. 436–452. 129 indexed citations
16.
Kumar, Devendra, Sukesh Kumar Gupta, Ankit Ganeshpurkar, et al.. (2018). Biological profiling of piperazinediones for the management of anxiety. Pharmacology Biochemistry and Behavior. 176. 63–71. 16 indexed citations
17.
Kumar, Devendra, Sukesh Kumar Gupta, Ankit Ganeshpurkar, et al.. (2018). Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 150. 87–101. 72 indexed citations
18.
Ganeshpurkar, Ankit, Devendra Kumar, & Sushil Kumar Singh. (2017). Design, synthesis and collagenase inhibitory activity of some novel phenylglycine derivatives as metalloproteinase inhibitors. International Journal of Biological Macromolecules. 107(Pt B). 1491–1500. 22 indexed citations
19.
Ganeshpurkar, Aditya, Ankit Ganeshpurkar, Divya Bansal, & Nazneen Dubey. (2014). Biological evaluation of ferulic acid as potent immunomodulator: An in vitro study. International Journal of Green Pharmacy. 8(2). 130. 1 indexed citations
20.
Ganeshpurkar, Aditya, Ankit Ganeshpurkar, Vikas Pandey, et al.. (2014). Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics. International Journal of Pharmaceutical Investigation. 4(1). 1–1. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026